MAZE β€” MAZE THERAPEUTICS INC

Ownership history in Mass General Brigham, Inc  Β·  1 quarter on record

This page tracks every 13F SEC filing in which Mass General Brigham, Inc reported a position in MAZE THERAPEUTICS INC (MAZE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
1.23% (2025 Q4)
πŸ“Š Avg. % of fund
1.23%
πŸ“… First filed
2025 Q4
πŸ“… Last filed
2025 Q4
⏱ Quarters held
1
% of Fund (quarterly)    MAZE price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 1 quarter  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 239,994 β€” β€” 1.23% $9.9M $41.43

🏒 Other funds also holding MAZE

As of 2025 Q4 β€” sorted by position size

TRV GP IV, LLC 3Y 72.65% Matrix Capital Management Company, LP 3Y 7Y 34.52% ARCH Venture Management, LLC 3Y 7Y 26.19% General Catalyst Group Management, LLC 3Y 7Y 19.35% Foresite Capital Management IV, LLC 3Y 7Y 9.43% TRV GP V, LLC 9.18% WASHINGTON UNIVERSITY 3Y 5.88% Frazier Life Sciences Management, L.P. 3Y 5.08% a16z Capital Management, L.L.C. 4.46% VR Adviser, LLC 3Y 3.17%
← Back to Mass General Brigham, Inc Holdings